Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Radiotherapeutics Market Snapshot: This Sector Is Getting Hot

Executive Summary

The radiotherapeutics sector is attracting a new and diverse group of biopharma players hoping to capitalize on the potential advantages offered by newer therapeutic radioisotopes.

Advertisement

Related Content

Algeta, Aspiring For Solo Success, Draws Bayer Bid After Xofigo Launch
Opening A Window: Algeta Must Find Xofigo’s Place In The Prostate Cancer Market
Bayer/Algeta’s Xofigo Brings New Mechanism To Prostate Cancer Field
Psoriasis Market Snapshot: An Area Drug Makers Are Itching To Get Into
Migraine Snapshot: Despite Significant Generic Presence, MAP, Allergan, Others See Big Market Potential
ESRD Market Snapshot: The Price Has To Be Right
Bayer Chief Worried About Innovation, Spanish Debts
Phase III Results For Bayer/Algeta's Alpharadin Hint Of Labeling Down The Line
Cancer Drug Zevalin May Finally Thrive Under Spectrum
Beauty Of Amgen Bone Drug Results Is In Eye Of The Beholder

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS054942

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel